IL-6 is directly associated with inflammatory lung conditions [36] and targeting IL-6 pathways can effectively treat a variety of inflammatory conditions and decrease mortality in severe COVID-19 cases [37–40]. This evidence concerns the gene IL6 and COVID-19.